Efficacy and tolerability of tirzepatide, a dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes: A 12‐week, randomized, double‐blind, placebo‐controlled study to evaluate different dose‐escalation regimens

AIM: To assess the efficacy and tolerability of tirzepatide treatment using three different dose‐escalation regimens in patients with type 2 diabetes. MATERIALS AND METHODS: In this double‐blind, placebo‐controlled study, patients were randomized (1:1:1:1) to receive either once‐weekly subcutaneous...

Descripción completa

Detalles Bibliográficos
Autores principales: Frias, Juan Pablo, Nauck, Michael A., Van, Joanna, Benson, Charles, Bray, Ross, Cui, Xuewei, Milicevic, Zvonko, Urva, Shweta, Haupt, Axel, Robins, Deborah A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318331/
https://www.ncbi.nlm.nih.gov/pubmed/31984598
http://dx.doi.org/10.1111/dom.13979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318331/
https://www.ncbi.nlm.nih.gov/pubmed/31984598
http://dx.doi.org/10.1111/dom.13979

Ejemplares similares